Plasmodium falciparum Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines
Plasmodium falciparum malaria is a disease causing high morbidity and mortality rates worldwide, mainly in sub-Saharan Africa. Candidates have been identified for vaccines targeting the parasite’s blood stage; this stage is important in the development of symptoms and clinical complications. However...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2019
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24091
- Acceso en línea:
- https://doi.org/10.3389/fmicb.2019.02712
https://repository.urosario.edu.co/handle/10336/24091
- Palabra clave:
- Ama 1 dico vaccine
Ama1 dico vaccine
Bk se36 vaccine
Erythrocyte binding protein 175 r2 ng vaccine
Gmz2 vaccine
Malaria vaccine
Msp3 lsp vaccine
Mva rh5 vaccine
P27a vaccine
Pfpebs vaccine
Placental malaria vaccine
Recombinant vaccine
Unclassified drug
Virus vector
Bioinformatics
Conformational transition
Cytokine release
Dna polymorphism
Emulsion
Gene expression system
Growth inhibition
Human
Humoral immunity
Immune response
Immunization
Immunogenicity
Malaria falciparum
Nonhuman
Phase 1 clinical trial (topic)
Phase 2 clinical trial (topic)
Review
Seroconversion
Vaccination
Antimalarial vaccine
Clinical trial
Immunogenicity
Malaria
Merozoite
Plasmodium falciparum
Vaccine
- Rights
- License
- Abierto (Texto Completo)